This deep dive into controversies in interstitial lung disease explored complex topics including IPAF, methotrexate, systemic autoimmune rheumatic disease vs. connective tissue disease distinctions, and the evolving role of anti-fibrotic therapy.
Panelists: Jeffrey Sparks, MD, Janet Pope, MD, Elena Joerns, MD
Jack Cush, MD - Moderator
